Sean Aurigemma
@Pier 88 Investment Partners Llc
Latest period2024 - Q3ReportedManaged Assets$453.922MTotal holdings91
Assets growth rate1.78%Assets growth rate (2-Q avg)5.69%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Pier 88 Investment Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 91 positions.
Assets under management
The assets under management (AUM) of Pier 88 Investment Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 453.922M in assets, with a quarterly growth rate of 1.78% and a 2-quarter average growth rate of 5.69%. The portfolio is managed by Sean Aurigemma, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ETSYEtsy Inc
| 0.2% | $891,812 16,060 shares@ $55.54 avg price | Increased 7.65% |
RXRXRecursion Pharmaceuticals In
| 0.2% | $882,467 133,910 shares@ $6.6 avg price | Increased 442.15% |
SYNASynaptics Inc
| 0.19% | $862,302 11,115 shares@ $77.59 avg price | Increased 28.21% |
SLABSilicon Laboratories Inc
| 0.15% | $678,627 5,872 shares@ $115.57 avg price | Increased 21.78% |
KRYSKrystal Biotech Inc
| 0.15% | $642,566 3,530 shares@ $182.04 avg price | Increased 5.06% |
RCKTRocket Pharmaceuticals Inc
| 0.14% | $600,090 32,490 shares@ $18.47 avg price | Increased 5.15% |
ABCLAbcellera Biologics Inc
| 0.12% | $508,300 195,500 shares@ $2.6 avg price | Increased 20.97% |
PYXSPyxis Oncology Inc
| 0.1% | $446,309 121,610 shares@ $3.68 avg price | Increased 6.96% |
AVGOBroadcom Inc
| 0.07% | $310,500 1,800 shares@ $172.5 avg price | Increased 47.55% |